Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin.
about
Visual field loss associated with vigabatrin: quantification and relation to dosage.Characterization of vigabatrin-associated optic atrophy.Neurotoxic effects of GABA-transaminase inhibitors in the treatment of epilepsy: ocular perfusion and visual performance.Does the Swedish Interactive Threshold Algorithm (SITA) accurately map visual field loss attributed to vigabatrin?Vigabatrin and visual field defects in pediatric epilepsy patients.Treatment of refractory complex partial seizures: role of vigabatrin.The value of electrophysiology results in patients with epilepsy and vigabatrin associated visual field loss.Rapid development of visual field defects associated with vigabatrin therapy.Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal.Detection of visual field defects in patients after anterior temporal lobectomy for mesial temporal sclerosis-establishing eligibility to drive.Vigabatrin-associated visual field constriction in a longitudinal series. Reversibility suggested after drug withdrawal.Vigabatrin: longterm follow-up of electrophysiology and visual field examinations.Vigabatrin-associated loss of vision: rarebit perimetry illuminates the dose-damage relationship.Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA.The ocular side effects of vigabatrin (Sabril): information and guidance for screening.
P2860
Q32154724-9F62CEE3-A08D-4AF8-8543-2E52FC97AFEDQ33972736-93A0C2BC-01C6-4B28-A6F5-9C9D1CF14AF0Q34928181-334DFB92-949A-432B-A196-AF292BBDBCE5Q35336784-18AE0E16-57D5-45D1-A879-E173E6964FFFQ37313207-8B249798-E949-4FAB-929D-18697D9C7B2CQ37620193-7CF27A27-2261-4F57-BD50-830EB7E37CF4Q43563762-B82FBBA0-10F3-4B3E-A733-664A96F302F9Q43795358-63DE5A73-35B9-4FF3-B25C-A2B37FC8479AQ44113272-4D016ABA-D43C-4EC8-B778-7DD7E9A4FB62Q44221494-A2C46F1C-7B48-4932-A36A-7C3A10142585Q44358411-82EFA6F8-7702-4EA8-AA4C-E37ED8FC7367Q44596992-477E5804-3671-4882-BE51-BE27D834FC5CQ44738388-AD3613E2-F823-4BA9-9D21-9038A9778667Q45030233-04ADF736-2FF4-4C2B-8E1C-FA9BE59D730BQ46580856-35AA06C2-3FAA-4698-8874-40F08C7DA54F
P2860
Long term changes in the visual fields of patients with temporal lobe epilepsy using vigabatrin.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Long term changes in the visua ...... obe epilepsy using vigabatrin.
@en
type
label
Long term changes in the visua ...... obe epilepsy using vigabatrin.
@en
prefLabel
Long term changes in the visua ...... obe epilepsy using vigabatrin.
@en
P2093
P2860
P356
P1476
Long term changes in the visua ...... obe epilepsy using vigabatrin.
@en
P2093
Berendschot TT
Verduin WM
van Veelen CW
P2860
P304
P356
10.1136/BJO.84.7.788
P407
P577
2000-07-01T00:00:00Z